Skip to main content

Systemic Amyloidosis due to Monoclonal Immunoglobulins, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition, Volume 34-6 - October 27, 2020
  • Latest edition
  • Editor: Raymond L. Comenzo
  • Language: English

This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Raymond L. Comenzo, is devoted to Systemic Amyloidosis due to Monoclonal Immunoglobulins. This issue is one of six… Read more

Purchase options

Description

This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Raymond L. Comenzo, is devoted to Systemic Amyloidosis due to Monoclonal Immunoglobulins. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: The Spectrum of Monoclonal Immunoglobulin Diseases, Systemic Amyloidosis due to Clonal Plasma Cell Diseases, Systemic Amyloidosis due to Low-grade Lymphomas, The Process of Amyloid Formation due to Monoclonal Immunoglobulins, Cardiac Involvement, Renal Involvement, Liver and Gastrointestinal Involvement, Peripheral Nervous System Involvement, Options for Chemotherapy, Stem-cell Mobilization and Autologous Transplant, Monoclonal Antibody Therapies, Solid Organ Transplant, Supportive Care, Patient Voices, and Future Perspectives.

Product details

  • Edition: 1
  • Latest edition
  • Volume: 34-6
  • Published: November 11, 2020
  • Language: English

About the editor

RC

Raymond L. Comenzo

Affiliations and expertise
By Raymond L. Comenzo, MD., Director, Transfusion Services Director, John C. Davis Myeloma and Amyloid Program Professor, Tufts University School of Medicine Tufts Medical Center and Tufts University School of Medicine Boston, MA, USA